From: The utility of biomarker risk prediction score in patients with chronic heart failure
Follow-up period | |||
---|---|---|---|
One year | Two years | Three years | |
Number of deaths, n | 15 | 33 | 43 |
Number of readmissions, n | 98 | 154 | 242 |
Actual all cause mortality rate, % | 3.9 | 8.5 | 11.1 |
Expected all cause mortality rate (%) estimated on Seattle Heart Failure Model | 3.6 (IQR =2–5) | 8.5 (IQR =6–12) | 8.5 (IQR =6–12) |
Expected all cause mortality rate (%) estimated on Heart Failure Risk Calculator | 4.8 (IQR =3,9–5,6) | - | 12.2 (IQR =10.4 – 14.7) |
Expected all cause mortality rate (%) estimated on Barcelona Bio-HF without NT-pro-BNP assay | 2.17 (IQR =2.3–2.5) | 4.81 (IQR =4.5–5.2) | 7.84 (IQR =7.22–8.36) |
Expected all cause mortality rate (%) estimated on Barcelona Bio-HF with NT-pro-BNP assay | 2.37 (IQR =2.33–2.47) | 5.25 (IQR =5.15–5.39) | 8.54 (IQR =8.20–8.82) |
Actual readmission rate, % | 25.3 | 39.6 | 62.4 |
Expected readmission rate, % | 21.5 (IQR = 15.6–29.7) | - | - |